Immediate Impact

2 by Nobel laureates 7 from Science/Nature 66 standout
Sub-graph 1 of 23

Citing Papers

Covalent targeted radioligands potentiate radionuclide therapy
2024 StandoutNature
Overall survival with sacituzumab govitecan in hormone receptor-positive and human epidermal growth factor receptor 2-negative metastatic breast cancer (TROPiCS-02): a randomised, open-label, multicentre, phase 3 trial
2023 Standout
2 intermediate papers

Works of Lawrence C. Swayne being referenced

Evaluation of a complementarity-determining region-grafted (humanized) anti-carcinoembryonic antigen monoclonal antibody in preclinical and clinical studies.
1995
Phase I clinical evaluation of a new murine monoclonal antibody (mu-9) against colon-specific antigen-p for targeting gastrointestinal carcinomas
1994

Author Peers

Author Last Decade Papers Cites
Lawrence C. Swayne 738 355 280 296 77 1.4k
Seyed Rasoul Zakavi 489 462 449 272 121 1.6k
J. Leclère 357 371 358 415 75 1.6k
Éric Frampas 438 395 258 403 91 1.3k
A.O. Langlands 281 383 371 506 81 1.7k
Sergio Venanzio Setola 749 374 502 526 91 1.6k
W Auffermann 362 309 262 149 56 1.3k
Robert C. Stadalnik 523 448 529 296 111 1.7k
Søren Hess 568 426 355 201 111 1.6k
Elliot K. Fishman 304 556 447 227 43 1.3k
Terue Okamura 426 415 352 255 71 1.4k

All Works

Loading papers...

Rankless by CCL
2026